• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Novel Approaches to Detect Significant Liver Disease in the General Population.

作者信息

Yeoman Andrew D

机构信息

Gwent Liver Unit Royal Gwent Hospital Newport United Kingdom.

出版信息

Clin Liver Dis (Hoboken). 2021 Sep 19;18(2):99-103. doi: 10.1002/cld.1097. eCollection 2021 Aug.

DOI:10.1002/cld.1097
PMID:34584677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8450484/
Abstract
摘要

相似文献

1
Novel Approaches to Detect Significant Liver Disease in the General Population.在普通人群中检测重大肝脏疾病的新方法。
Clin Liver Dis (Hoboken). 2021 Sep 19;18(2):99-103. doi: 10.1002/cld.1097. eCollection 2021 Aug.
2
The spectrum of the liver disease in the general population: lesson from the Dionysos Study.普通人群中肝脏疾病的谱：来自狄俄尼索斯研究的经验教训。
Med Arh. 2002;56(1 Suppl 1):29-30.
3
Increased risk of chronic liver disease in patients with schizophrenia: a population-based cohort study.精神分裂症患者患慢性肝病风险增加：一项基于人群的队列研究。
Psychosomatics. 2014 Mar-Apr;55(2):163-71. doi: 10.1016/j.psym.2013.06.001. Epub 2013 Aug 9.
4
Risk Assessment of Hepatocellular Carcinoma in General Population by Liver Stiffness in Combination with Controlled Attenuation Parameter using Transient Elastography: A Cross Sectional Study.基于瞬时弹性成像技术，联合肝脏硬度值与受控衰减参数对普通人群肝细胞癌进行风险评估的横断面研究
Yonago Acta Med. 2017 Jun 26;60(2):106-112. eCollection 2017 Jun.
5
Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease.评估非酒精性脂肪性肝病肝脂肪含量的成像技术
Ann Hepatol. 2008 Jul-Sep;7(3):212-20.
6
Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.基层医疗临床医生对非酒精性脂肪性肝病认识不足：对纤维化替代标志物的认识有限。
Intern Med J. 2018 Feb;48(2):144-151. doi: 10.1111/imj.13667.
7
Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.非酒精性脂肪性肝病 (NAFLD) 的诊断：现状。
Curr Pharm Des. 2018;24(38):4574-4586. doi: 10.2174/1381612825666190117102111.
8
Increased risk of chronic liver disease in patients with bipolar disorder: A population-based study.双相情感障碍患者患慢性肝病的风险增加：一项基于人群的研究。
Gen Hosp Psychiatry. 2016 Sep-Oct;42:54-9. doi: 10.1016/j.genhosppsych.2016.07.006. Epub 2016 Jul 25.
9
[Controlled attenuation parameter is a novel technique in screening for non-alcoholic fatty liver disease].[受控衰减参数是筛查非酒精性脂肪性肝病的一项新技术]
Ugeskr Laeger. 2018 Jan 29;180(5).
10
The human liver matrisome - Proteomic analysis of native and fibrotic human liver extracellular matrices for organ engineering approaches.人类肝脏基质组——用于器官工程方法的天然和纤维化人类肝脏细胞外基质的蛋白质组学分析。
Biomaterials. 2020 Oct;257:120247. doi: 10.1016/j.biomaterials.2020.120247. Epub 2020 Jul 24.

引用本文的文献

1
Screening high-risk Veterans for cirrhosis: taking a stepwise population health approach.对高危退伍军人进行肝硬化筛查：采取循序渐进的人群健康方法。
BMC Health Serv Res. 2025 Jan 29;25(1):168. doi: 10.1186/s12913-025-12216-8.
2
Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease.脂肪肝指数在非酒精性脂肪性肝病合并症风险分层中的作用。
JHEP Rep. 2023 Aug 24;5(12):100896. doi: 10.1016/j.jhepr.2023.100896. eCollection 2023 Dec.
3
Liver Diseases in Latin America: Current Status, Unmet Needs, and Opportunities for Improvement.拉丁美洲的肝脏疾病：现状、未满足的需求及改善机遇
Curr Treat Options Gastroenterol. 2022;20(3):261-278. doi: 10.1007/s11938-022-00382-1. Epub 2022 Jun 16.

本文引用的文献

1
The Development and Implementation of a Commissioned Pathway for the Identification and Stratification of Liver Disease in the Community.社区肝病识别与分层委托路径的制定与实施
Frontline Gastroenterol. 2020 Feb 10;11(2):86-92. doi: 10.1136/flgastro-2019-101177. Epub 2019 Jun 26.
2
Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care.智能肝功能检测(iLFT)：在初级保健中自动诊断和分期肝病的试验。
J Hepatol. 2019 Oct;71(4):699-706. doi: 10.1016/j.jhep.2019.05.033. Epub 2019 Jun 19.
3
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease.前瞻性评估非酒精性脂肪性肝病患者的初级保健转诊途径。
J Hepatol. 2019 Aug;71(2):371-378. doi: 10.1016/j.jhep.2019.03.033. Epub 2019 Apr 6.
4
Burden of liver diseases in the world.世界范围内的肝脏疾病负担。
J Hepatol. 2019 Jan;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014. Epub 2018 Sep 26.
5
Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.增强型肝纤维化试验与 FibroTest、瞬时弹性成像和间接标志物在诊断酒精性肝病患者中晚期纤维化的准确性比较。
Gastroenterology. 2018 Apr;154(5):1369-1379. doi: 10.1053/j.gastro.2018.01.005. Epub 2018 Jan 6.
6
Guidelines on the management of abnormal liver blood tests.肝脏血液检查异常的管理指南。
Gut. 2018 Jan;67(1):6-19. doi: 10.1136/gutjnl-2017-314924. Epub 2017 Nov 9.
7
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.年龄作为晚期非酒精性脂肪性肝病纤维化准确无创诊断的混杂因素。
Am J Gastroenterol. 2017 May;112(5):740-751. doi: 10.1038/ajg.2016.453. Epub 2016 Oct 11.
8
Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study.伯明翰和兰贝斯肝脏评估测试策略（BALLETS）：一项前瞻性队列研究。
Health Technol Assess. 2013 Jul;17(28):i-xiv, 1-307. doi: 10.3310/hta17280.
9
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.简单的非侵入性纤维化评分系统可以可靠地排除非酒精性脂肪性肝病患者的晚期纤维化。
Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077.
10
Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE).肝功能检查异常但无临床明显肝病患者基层医疗管理决策支持工具的开发：一项记录链接人群队列研究与决策分析（ALFIE）
Health Technol Assess. 2009 Apr;13(25):iii-iv, ix-xi, 1-134. doi: 10.3310/hta13250.